Market Closed

MTVA
MetaVia
$ 1.30
0.00%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated a day ago

MetaVia News

Latest MetaVia Stock News & MTVA Headlines

MetaVia Reports Third Quarter 2026 Financial Results and Provides Corporate Update
2 days ago | prnewswire.com
MetaVia's Potential Drug Candidate Cuts Serum Uric Acid and Liver Fat
3 days ago | benzinga.com
MetaVia Announces Statistically Significant Reduction in Uric Acid Levels with DA-1726 in Phase 1 Part 3B Clinical Trial
3 days ago | prnewswire.com
MetaVia Announces Poster Presentation on DA-1726 at ObesityWeek® 2026
6 days ago | prnewswire.com
MetaVia Announces Statistically Significant 68% Reduction in Liver Fat from DA-1726 Phase 1 Part 3B Interim Data
10 days ago | prnewswire.com
MetaVia to Present Phase 1 Clinical Trial Data for DA-1726 in Oral Presentation at the Precision Liver Symposium 2026
18 days ago | prnewswire.com
MetaVia Appoints Seasoned Clinical Development Executive Sarah Browne, M.D., as Chief Medical Officer
a month ago | prnewswire.com
MetaVia Announces Preclinical Findings Supporting Biological Rationale for DA-1726's Waist Circumference Reduction
2 months ago | prnewswire.com
MetaVia Reports Second Quarter 2026 Financial Results and Provides Corporate Update
3 months ago | prnewswire.com
MetaVia to Highlight Novel Obesity and Metabolic Therapies at Upcoming Life Sciences Virtual Investor Forum
5 months ago | prnewswire.com
Load More

Download App

Keep track of your holdings and explore over 40,000 cryptocurrencies

oinCodex Android App
CoinCodex Mobile App
Market Closed

MTVA
MetaVia
$ 1.30
0.00%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated a day ago